Initiatives

BG Medicine is applying its proprietary systems biology biomarker discovery platform to some of the pharmaceutical industry's greatest challenges and to important global healthcare problems.

	Partnering with the Framingham Heart Study to solve the biggest medical problem.
	Leading a pre-competitive approach to solve the leading cause of heart attacks.
	Leading a FDA Critical Path Initiative to discover new biomarkers of liver toxicity.